<div id="main-content">
<h2 class="title"><span class="in"><span style="color: rgb(255, 255, 255);">Allosterism</span></span></h2>
<div class="article">
<div class="article-content">
<div class="RichTextElement">
<div><p><br/><span style="font-size: 16px; font-family: Arial;">Allosteric regulation (allosterism) is the modulation of an enzymeâs activity via the binding of an effector molecule (ligand) to a site <em>other</em> than the enzymeâs active site (an allosteric site)</span></p><ul><li><span style="font-size: 16px; font-family: Arial;">Allosteric binding causes a conformational change in the enzymeâs structure which affects the enzymeâs affinity for substrate</span></li><li><span style="font-family: Arial; font-size: 16px;">Allosteric regulation can be either positive (activation) or negative (non-competitive inhibition)</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/><strong><u>Positive Allosterism</u></strong></span></p><ul><li><span style="font-size: 16px; font-family: Arial;">An example of allosteric activation is seen in the binding of oxygen molecules to haemoglobin</span></li><li><span style="font-size: 16px; font-family: Arial;">Haemoglobin is composed of four distinct subunits and can bind up to four oxygen molecules (HbO<sub>8</sub>)</span></li><li><span style="font-size: 16px; font-family: Arial;">As each oxygen molecule binds, it changes the conformation of haemoglobin and increases its affinity for oxygen</span></li><li><span style="font-size: 16px; font-family: Arial;">This ensures that haemoglobin will transport the maximum amount of oxygen from oxygen-rich areas (i.e. the lungs)</span></li><li><span style="font-size: 16px; font-family: Arial;">Conversely, the release of an O<sub>2</sub> molecule decreases haemoglobinâs affinity for oxygen â promoting its release in the tissues</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/><strong><u>Negative Allosterism</u></strong></span></p><ul><li><span style="font-size: 16px; font-family: Arial;">An example of allosteric inhibition can be seen in any example of non-competitive inhibition</span></li><li><span style="font-size: 16px; font-family: Arial;">Phosphofructokinase (PFK) is an enzyme involved in the breakdown of glucose during glycolysis (to make ATP)</span></li><li><span style="font-size: 16px; font-family: Arial;">ATP binds to an allosteric site on PFK and inhibits its activity â preventing glycolysis from occurring</span></li><li><span style="font-size: 16px; font-family: Arial;">Thus ATP prevents the further production of more ATP when energy stocks are high (end-product inhibition)</span></li><li><span style="font-size: 16px; font-family: Arial;">When energy stocks are low, there is insufficient ATP to inhibit PFK and glycolysis will be able to proceed</span></li></ul><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p><p style="text-align: center;"><u><span style="font-size: 18px; font-family: Arial;"><strong>Allosteric Regulation</strong></span></u></p>
<div class="first graphic-container wide center ImageElement">
<div class="graphic">
<div class="figure-content">
<!-- sandvox.ImageElement --><img alt="allosterism" height="238" src="../../../_Media/allosterism_med.jpeg" width="800"/>
<!-- /sandvox.ImageElement --></div>
</div>
</div><p><span style="font-size: 16px; font-family: Arial;"><br/></span></p>
</div>
</div>
</div> <!-- /article-content -->
<div class="article-info">
</div> <!-- /article-info -->
</div> <!-- /article -->
</div>